FewerJobs.
Employers

Employer profile

Mbx Biosciences Inc

11 open roles indexed with location, benefit, and apply-link signals where available.

ATS: greenhouse

Open roles

Showing the most recent indexed roles for this employer.

Search all matching jobs
  • Director, IT Infrastructure and Security

    Burlington, MA

    unspecified Salary not disclosed

    Director, IT Infrastructure and Security Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You will Do The Director, IT Infrastructure and Security, is a hands-on leader responsible for the reliability, security and scalability of the technology environment that supports MBX Biosciences as we advance our pipeline toward late-stage development. Reporting to the VP, IT, you will build and scale

  • Clinical Scientist (Late Stage)

    Burlington, MA

    unspecified Salary not disclosed

    Clinical Scientist (Late Stage) Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do The Clinical Scientist will provide clinical and scientific expertise to deliver clinical studies in early- and/or late-stage development. This individual will be responsible for the hands-on implementation and execution of assigned clinical studies under the supervision of a Director/Senior Director in Clinical Development. This individual

  • Payroll Specialist

    Burlington, MA or Carmel, IN

    unspecified Salary not disclosed

    Payroll Specialist Burlington, MA or Carmel, IN Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do MBX Biosciences is seeking a Payroll Specialist to be responsible for timely and accurate payroll processing and related tax reporting for MBX Biosciences. Key responsibilities will include handling payroll functions, including handling semi-monthly payroll preparation, managing deductions, and addressing any payroll-related inquiries. You will

  • Director, Clinical Operations (Obesity)

    Burlington, MA

    unspecified Salary not disclosed

    Director, Clinical Operations (Obesity) Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do MBX Biosciences is seeking an experienced and highly motivated Director, Clinical Operations to lead the execution of clinical trials across our early-phase obesity portfolio. Reporting to the Head of Clinical Operations, this individual will provide operational leadership for Phase 1 and early Phase 2 studies,

  • Associate Director, QA Oversight for QC

    Burlington, MA

    unspecified Salary not disclosed

    Associate Director, QA Oversight for QC Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do The Associate Director of QA Oversight for QC and CTO provides strategic leadership and independent compliance oversight for all internal Quality Control (QC) operations and external Contract Testing Organizations (CTOs). This role ensures that all product testing, stability programs, and environmental monitoring workflows-whether

  • Scientist, Peptide Chemistry

    Greater Boston Area

    unspecified Salary not disclosed

    Scientist, Peptide Chemistry Greater Boston Area Position Summary MBX Biosciences is looking for a talented and motivated Peptide Chemist to join our dynamic research and development team. The successful candidate will be instrumental in designing, synthesizing, and characterizing novel peptides to support our drug discovery programs. Reporting to our Director of Chemistry, this position provides an excellent opportunity to work at the forefront of peptide therapeutics within a collaborative and innovative environment. Key Responsibilities - Synthesize peptides and peptide analogs using advanced techniques, such as solid-phase peptide synthesis and solution-phase synthesis. Experience with Solid-phase peptide synthesis is highly desirable. - Perform the purification and characterization of peptides using HPLC, mass spectrometry, and other analytical techniques. - Contribute to the design and modification of peptides to enhance pharmacological properties, including stability, bioavailability, and target specificity. - Collaborate with cross-functional teams, including biology, pharmacology, and formulation scientists, to advance peptide candidates. - Maintain accurate and detailed experimental records, and prepare technical reports and presentations. - Maintain and support highly organized laboratory including consumables and reagent ordering and tracking - Stay up to date with the latest advancements in peptide chemistry and related fields through literature reviews and participation in scientific conferences. Education & Qualifications - PhD or MS in Analytical Chemistry, Biochemistry, Chemistry, or a related field; or, BS in Analytical Chemistry, Biochemistry, Chemistry, or a related field with a minimum of 2 years of relevant experience. - Demonstration of strong scientific and leadership skills that drive results. - Must demonstrate excellent

  • Senior Scientist, Drug Substance

    Burlington, MA

    unspecified Salary not disclosed

    Senior Scientist, Drug Substance Burlington, MA Position Summary The Senior Scientist, Drug Substance will drive the development and optimization of scalable, efficient, and sustainable synthetic routes for MBX's peptide drug substances and intermediates. In this role, you'll support late‑stage development activities, contribute to QbD initiatives, and help define control strategies aligned with global regulatory expectations. You will provide technical leadership and oversight for external CDMOs, supporting manufacturing campaigns, tech transfers, troubleshooting, and investigations. Collaboration across Discovery, Analytical Chemistry, Quality, Regulatory CMC, and Clinical teams is essential, as is the ability to work effectively with external consultants and manufacturing partners. Key Responsibilities - Design, develop, and optimize robust, cost-effective synthetic routes to drug substance, drug substance intermediates and starting materials, with a focus on step reduction, convergence, scalability, efficiency and sustainability. - Contribute to the development and execution of control strategies in alignment with global regulatory expectations. - Support the qualification, technical oversight, and ongoing management of CDMOs manufacturing and releasing MBX's peptide drug substance projects. - Lead and support manufacturing campaigns for products at external CDMOs. - Participate in technical transfers, process troubleshooting, and manufacturing investigations at partner sites. - Contribute to Quality-by-Design (QbD) activities for late-stage development, including risk assessments, identification of critical quality attributes (CQAs), and establishment of control strategies. - Support process engineering, scale-up, and process safety studies in collaboration with internal and external experts. - Assist with analytical method development, qualification, and validation strategies as they relate to stage-appropriate drug substance development and manufacturing. - Author

  • Quality Systems & Compliance Specialist

    Burlington, MA

    unspecified Salary not disclosed

    Quality Systems & Compliance Specialist Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do MBX Biosciences is seeking a highly motivated Quality Systems & Compliance Specialist to oversee and continuously enhance key elements of the Quality Management System (QMS), including Document Control, GxP Training, and Service Provider Lifecycle Management. This individual will play a critical role in ensuring

  • Regulatory Affairs Fellow

    Burlington, MA

    unspecified Salary not disclosed

    Regulatory Affairs Fellow Burlington, MA Position Summary The MBX Biosciences, Inc. (MBX) Regulatory Affairs Fellow position is being offered in collaboration with Purdue University through the College of Pharmacy's Pharmaceutical Industry-Affiliated Fellowships Program. Over the course of 2-years, the PharmD Fellow will split their time between MBX (~ 90%) and Purdue University College of Pharmacy (~10%). While at MBX, the selected candidate will have the opportunity to work on projects and teams across the Regulatory function, including Regulatory Science, Regulatory Chemistry, Manufacturing, and Controls (CMC), Regulatory Operations, and Quality. The fellow will spend the first 18 months rotating throughout the different functions of the Regulatory Department and may choose to move to another MBX department (eg, Clinical Science, Medical Affairs, Drug Safety/PVG, Commercial, etc…) for a 6-month optional rotation pending management approval. The Purdue University College of Pharmacy component of this fellowship will allow the selected candidate to participate in numerous networking and professional development opportunities each year. These include eligibility to complete the Indiana Pharmacy Teaching Certification (IPTeC) Program, workshops for CV construction and mock Interviews, the MidWest industry Pharmacists Symposium, a Purdue reception at ASHP Midyear, and more. Travel & Hybrid Expectation You will be expected to travel periodically based on the needs of the business, including attendance at Together Weeks, Together Days, and functional meetings as requested by the team. Employees are expected to work on hybrid schedules, consistent with local office practices and the terms of the companies in office policy as in effect from time

  • Senior Manager, Clinical Data Management

    Burlington, MA

    unspecified Salary not disclosed

    Senior Manager, Clinical Data Management Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . What You'll Do The Senior Manager, Clinical Data Management (CDM), reporting to Director, Clinical Data Strategy and Management, will play a pivotal role in a dynamic, cross-functional clinical development team focused on advancing treatments for endocrine and metabolic disorders. This role will provide hands-on leadership on day-to-day

  • Associate Director, Statistical Programming

    Burlington, MA

    unspecified Salary not disclosed

    Associate Director, Statistical Programming Burlington, MA Working with Us MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA. Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides. Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential. Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform. If you're passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team. To learn more, visit our website mbxbio.com and follow us on LinkedIn . Position Summary MBX is seeking an Associate Director, Statistical Programming to lead and contribute to statistical programming and analysis of clinical trial data. This role is integral to the design, execution, and interpretation of analyses for clinical trials and related research activities. The Associate Director will ensure